
News|Articles|November 12, 2014
Essentra to Acquire Clondalkin's Specialist Packaging Division
Author(s)Pharmaceutical Technology Editors
Essentra has signed an agreement to acquire Clondalkin's Specialist Packaging Division for a cash consideration of approximately $455 million.
Advertisement
Essentra has signed an agreement to acquire Clondalkin’s Specialist Packaging Division for a cash consideration of approximately $455 million. According to the press release, the transaction marks Essentra’s largest acquisition to date and is expected to complete in the first quarter of 2015.
Clondalkin SPD is a global provider of speciality secondary packaging solutions for the pharmaceutical and health and personal care industries, with 24 facilities. It is believed that the acquisition will add to Essentra’s position in these markets.
Source:
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy
2
European Biotechs Reshaping Respiratory Disease
3
Midyear 2026 Industry Report: Taking Stock of Pharma Manufacturing, AI, and Regulatory Trends
4
Six Months In: A 2026 Progress Check on Pharma Manufacturing, AI, and Regulatory Shifts
5




